Current Pain and Headache Reports

, Volume 8, Issue 5, pp 369–378 | Cite as

History of fibromyalgia: Past to present

  • F. Fatma Inanici
  • Muhammad B. Yunus


Fibromyalgia syndrome (FMS) is now a recognized clinical entity causing chronic and disabling pain. For several centuries, muscle pains have been known as rheumatism and then as muscular rheumatism. The term fibrositis was coined by Gowers in 1904 and was not changed to fibromyalgia until 1976. Smythe laid the foundation of modern FMS in 1972 by describing widespread pain and tender points. The first sleep electroencephalogram study was performed in 1975. The first controlled clinical study with validation of known symptoms and tender points was published in 1981. This same study also proposed the first data-based criteria. The important concept that FMS and other similar conditions are interconnected was proposed in 1984. The first American College of Rheumatology criteria were published in 1990 and neurohormonal mechanisms with central sensitization were developed in the 1990s. Serotonergic/norepinephric drugs were first shown to be effective in 1986.


Irritable Bowel Syndrome Fibromyalgia Chronic Fatigue Syndrome Tender Point Fibromyalgia Impact Questionnaire 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Ruhman W: The earliest book on rheumatism. Br J Rheumatol 1940, 2:140–162.Google Scholar
  2. 2.
    Block SR: Fibromyalgia and the rheumatisms: common sense and sensibility. Rheum Dis Clin North Am 1993, 19:61–78.PubMedGoogle Scholar
  3. 3.
    Valleix FL: Traite Des Nervalgies ou Affections Douloureuses Des Nerfs. Paris: JB Bailliere; 1841:266–594.Google Scholar
  4. 4.
    Froriep R: Ein Beitrag zur Pathologie des Rheumatismus. Weimar: 1843.Google Scholar
  5. 5.
    Baldry PE: The evolution of current concepts. In Myofascial Pain and Fibromyalgia Syndromes. Edited by Baldry PE. Edinburg: Churchill Livingstone; 2001:3–15.Google Scholar
  6. 6.
    Beard GM: A Practical Treatise on Nervous Exhaustion (Neurasthenia). New York: William Wood and Co; 1880.Google Scholar
  7. 7.
    Gowers WR: Lumbago: its lessons and analogues. BMJ 1904, i:117–121. First coining of the term fibrositis, which was used for the next 72 years.Google Scholar
  8. 8.
    Telling WH: Nodular fibromyositis: an everyday affliction and its identity with so-called muscular rheumatism. Lancet 1911, 1:154–158.Google Scholar
  9. 9.
    Schade H: Untersuchungen in der Erkaltungsfrage. III: Ueber den rheumatismus, insbesondere den muskelrheumatismus (myogelose). Munch Med Wschr 1921, 68:418–420.Google Scholar
  10. 10.
    Lange F, Everbusch G: Die Bedeutung der Muskelharten fur die allgemeine Praxis. Munich Med Wochenschr 1921, 68:418–420.Google Scholar
  11. 11.
    Albee F: Myofasciitis: a pathological explanation of any apparently dissimilar conditions. Am J Surg 1927, 3:523–533.Google Scholar
  12. 12.
    Murray G: Myofibrositis as simulator of other maladies. Lancet 1929, 1:113–116.Google Scholar
  13. 13.
    Clayton EG: Fibrositis. Lancet 1930, 1:420–1423.Google Scholar
  14. 14.
    Rowe AH: Allergic toxemia and migraine due to food allergy. Calif West Med J 1930, 33:785.Google Scholar
  15. 15.
    Halliday JL: Psychological factors in rheumatism. BMJ 1937, i:213–217, 264–269.Google Scholar
  16. 16.
    Thompson JM: Tension myalgia as a diagnosis at the Mayo Clinic and its relationship to fibrositis, fibromyalgia, and myofascial pain syndrome. Mayo Clin Proc 1990, 65:1237–1248.PubMedGoogle Scholar
  17. 17.
    Randolph T: Allergic myalgia. J Michigan State Med Soc 1951, 50:487.Google Scholar
  18. 18.
    Travell J, Rinzler S, Herman M: Pain and disability of the shoulder and arm: treatment by intramuscular infiltration with procaine hydrochloride. JAMA 1942, 120:417–434.Google Scholar
  19. 19.
    Raspe H: Rheumatism epidemiology in Europe. Soz Praventivmed 1992, 37:168–178.PubMedGoogle Scholar
  20. 20.
    Awad EA: Interstitial myofibrositis: hypothesis of the mechanism. Arch Phys Med Rehabil 1973, 54:449–453.PubMedGoogle Scholar
  21. 21.
    Hench PK: Nonarticular rheumatism, 22nd rheumatism review: review of the American and English literature for the years 1973 and 1974. Arthritis Rheum 1976, 19(suppl):1081–1089.Google Scholar
  22. 22.
    Balfour W: Observations on the pathology and cure of rheumatism. Edinb Med Surg J 1815, 11:168–187.Google Scholar
  23. 23.
    Scudamore C: A Treatise on the Nature and Aure of Rheumatism. London; 1827:II.Google Scholar
  24. 24.
    Inman T: Remarks on myalgia or muscular pain. BMJ 1858, 407–408.Google Scholar
  25. 25.
    Cornelius A: Narben und nerven: deutsche militatarztlische. Zeitschrift 1903, 32:657–673.Google Scholar
  26. 26.
    Virchow R: Ueber parenchymatose entzundung. Arch Pathol Anat 1852, 4:261–279.Google Scholar
  27. 27.
    Reynolds MD: The development of the concept of fibrositis. J.History Med Allied Sci 1983, 38:5–35.Google Scholar
  28. 28.
    Strauss H: Uber die sogenannte “rheumatische muskelschwiele.” Klin Wochenschr 1898, 35:89–91, 121–123.Google Scholar
  29. 29.
    Port K: Eine fur den orthopaden wichtige gruppe des chronischen rheumatismus (Knotchenrheumatismus). Arch Orthop Unfallchir 1920, 17:465–506.Google Scholar
  30. 30.
    Haberling W: Johan Georg Mezger of Amsterdam: the founder of scientific massage. Med Life 1932, 39:190–207.Google Scholar
  31. 31.
    Graham D: Massage in muscular rheumatism and its possible value in the diagnosis of muscular rheumatism from neuritis. Am J Med Sci 1893, 106:190–198.Google Scholar
  32. 32.
    Stockman R: The causes, pathology, and treatment of chronic rheumatism. Edinb Med J 1904, 15:107–116.Google Scholar
  33. 33.
    Schmidt A: Der muskelrheumatismus (myalgie) auf grund eigener beobachtungen und untersuchungen gemeinvestandlich dargestelli. Bonn 1918, 46–47.Google Scholar
  34. 34.
    Abel O Jr, Siebert WJ: Fibrositis. J Mo Med Assoc 1939, 36:435–437.Google Scholar
  35. 35.
    Collins DH: Fibrositis and infection. Ann Rheum Dis 1940, 2:114–125.PubMedGoogle Scholar
  36. 36.
    Slocumb CH: Fibrositis. Ann Rheum Dis 1943, 2:169–178.Google Scholar
  37. 37.
    Yunus MB, Kalyan-Raman UP, Masi AT, Aldag JC: Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol 1989, 16:97–101. The first controlled and blinded evaluation of muscle histology in FMS showing normal results. The findings helped to focus on central mechanisms.PubMedGoogle Scholar
  38. 38.
    Osler W: The Principles and Practice of Medicine, edn 7. New York: Appleton; 1909.Google Scholar
  39. 39.
    Llewellyn LJ, Jones AB: Fibrositis. London: William Heinemann; 1913.Google Scholar
  40. 40.
    Slocumb CH: Differential diagnosis of periarticular fibrositis and arthritis. Proc Staff Meet Mayo Clin 1936, 11:363–368.Google Scholar
  41. 41.
    Reichart A: Reflexschmerzen auf grund von myoglosen. Dtsch Med Wochenschr 1938, 64:823–824.Google Scholar
  42. 42.
    Gutstein M: Diagnosis and treatment of muscular rheumatism. Br J Phys Med 1938, 1:302–321.Google Scholar
  43. 43.
    Steindler A: The interpretation of sciatic radiation and the syndrome of low back pain. J Bone Joint Surg 1940, 22:28–34.Google Scholar
  44. 44.
    Kellgren JH: Observations on referred pain arising from muscle. Clin Sci 1938, 3:175–190.Google Scholar
  45. 45.
    Kellgren JH: On distribution of pain arising from deep somatic structures with charts of segmental pain areas. Clin Sci 1939, 4:35–46.Google Scholar
  46. 46.
    Kelly M: The treatment of fibrositis and allied disorders by local anesthesia. Med J Aust 1941, 1:294–298.Google Scholar
  47. 47.
    Kelly M: Local injections for rheumatism. Med J Aust 1962, 1:4–7.Google Scholar
  48. 48.
    Travell J, Rinzler S: Myofascial genesis of pain. Postgrad Med 1952, 11:425–434.PubMedGoogle Scholar
  49. 49.
    Bach F: Physical medicine in the treatment of rheumatic diseases in the armed forces an impression of the war years. Arch Phys Med 1947, 27:734–737.Google Scholar
  50. 50.
    Beeson P, Scott T: Clinical epidemiological and experimental observations in an acute myalgia of the neck and shoulders: its possible relation to certain cases of generalized fibrositis. Proc R Soc Med 1942, 35:733–740.Google Scholar
  51. 51.
    Boland P, Corr W: Psychogenic rheumatism. JAMA 1943, 123:805–809.Google Scholar
  52. 52.
    Ellman P, Savage OA, Wittkower E, Rodger TF: A biographical study of fifty civilian and military cases from the Rheumatic unit, St Stephen’s Hospital (London County Council), and a military hospital. Ann Rheum Dis 1942, 3:56–76.CrossRefPubMedGoogle Scholar
  53. 53.
    Halliday JL: The obsession with fibrositis. BMJ 1942, 1:164.CrossRefGoogle Scholar
  54. 54.
    Graham W: Fibrositis. In Arthritis and Allied Conditions, edn 4. Edited by Hollander JL. Philadelphia: Lea & Febiger; 1949:622–647.Google Scholar
  55. 55.
    Copeman WS, Pugh LG: Effect of artificial dehydration in rheumatism. Lancet 1945, 2:553–555.Google Scholar
  56. 56.
    Leavitt F, Katz RS, Golden HE, et al.: Comparison of pain properties in fibromyalgia patients and rheumatoid arthritis patients. Arthritis Rheum 1986, 29:775–781.PubMedGoogle Scholar
  57. 57.
    Traut EF: Fibrositis. J Am Geriatr Soc 1968, 16:531–538.PubMedGoogle Scholar
  58. 58.
    Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160–172. This multicenter study set the criteria for uniform classification of FMS for research purposes that have been used all over the world. These criteria also are helpful for clinical diagnosis.PubMedGoogle Scholar
  59. 59.
    Wolfe F, Ross K, Anderson J, Russell IJ: Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 1995, 22:151–156.PubMedGoogle Scholar
  60. 60.
    Yunus MB, Inanici F, Aldag JC, Mangold RF: Fibromyalgia in men: comparison of clinical features with women. J Rheumatol 2000, 27:485–490.PubMedGoogle Scholar
  61. 61.
    Smythe H: Nonarticular rheumatism and psychogenic musculoskeletal syndromes. In Arthritis and Allied Conditions, edn 8. Edited by McCarty DJ. Philadelphia: Lea & Febiger; 1972:881–891. The first description of modern day fibromyalgia with widespread pain and multiple tender points that generated research interest.Google Scholar
  62. 62.
    Moldofsky H, Scarisbrick P, England R, Smythe H: Musculoskeletal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med 1975, 37:341–351. The first study of sleep encephalogram in FMS showing arousal in non-REM sleep.PubMedGoogle Scholar
  63. 63.
    Smythe HA, Moldofsky H: Two contributions to understanding of the “fibrositis” syndrome. Bull Rheum Dis 1977-1978, 28:928–931.Google Scholar
  64. 64.
    Yunus M, Masi AT, Calabro JJ, et al.: Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981, 11:151–171. This is the first controlled study of the clinical characteristics of FMS that provided the first data-based criteria for FMS. It also confirmed previous anecdotally described symptoms and a high number of tender points in FMS and added new features, including association of fibromyalgia with IBS and headaches.PubMedGoogle Scholar
  65. 65.
    Yunus MB: Symptoms and signs of fibromyalgia syndrome: an overview. In Text Book of Fibromyalgia and Other Non-neuropathic Chronic Pain Syndromes. Edited by Wallace DJ, Clauw DJ. Philadelphia: Lippincott Williams & Wilkins; in press.Google Scholar
  66. 66.
    Yunus MB: The concept of central sensitivity syndromes. In Text Book of Fibromyalgia and Other Non-neuropathic Chronic Pain Syndromes. Edited by Wallace DJ, Clauw DJ. Philadelphia: Lippincott Williams & Wilkins; in press. An important chapter that describes the concept of central sensitivity syndromes and reviews all of the currently available evidence for mutual associations and central sensitization among FMS and related conditions.Google Scholar
  67. 67.
    Yunus MB: Fibromyalgia: a need for uniform classification. J Rheumatol 1983, 10:841–844.PubMedGoogle Scholar
  68. 68.
    Yunus MB: Primary fibromyalgia syndrome: current concepts. Compr Ther 1984, 10:21–28. The first article that depicts the interconnectedness between FMS and similar syndromes by a Venn diagram.PubMedGoogle Scholar
  69. 69.
    Hudson JI, Pope HG Jr: Fibromyalgia and psychopathology:Is fibromyalgia a form of “affective spectrum disorder?” J Rheumatol 1989, 19(suppl):15–22. This article proposes overlaps between FMS and related conditionsas well as several psychiatric conditions. All of these syndromes later were proposed to be connected by central sensitization rather than by affective mechanism.Google Scholar
  70. 70.
    Bennett RM: Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 1999, 74:385–398. A useful review of central sensitization in FMS.PubMedGoogle Scholar
  71. 71.
    Yunus MB: Central sensitivity syndromes: a unified concept for fibromyalgia and other similar maladies. J Indian Rheumatism Assoc 2000, 8:27–33. An important review of evidence for central sensitization in FMS and other related disorders. It also suggests a new terminology of “central sensitivity syndromes” for these disorders.Google Scholar
  72. 72.
    Yunus MB, Masi AT: Juvenile fibromyalgia syndrome: a clinical study of 33 patients and matched normal controls. Arthritis Rheum 1985, 28:138–145.PubMedGoogle Scholar
  73. 73.
    Yunus MB: Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 1992, 19:846–850. An editorial that proposes a model for FMS pathogenesis with emphasis on aberrant central pain mechanisms interacting with peripheral factors.PubMedGoogle Scholar
  74. 74.
    Wolfe F, Cathey MA, Kleinheksel SM: Fibrositis (fibromyalgia) in rheumatoid arthritis. J Rheumatol 1984, 11:814–818.PubMedGoogle Scholar
  75. 75.
    Wolfe F, Ross K, Anderson J, et al.: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995, 38:19–28.PubMedGoogle Scholar
  76. 76.
    White KP, Speechley M, Harth M, Ostbye T: The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada. J Rheumatol 1999, 26:885–889.PubMedGoogle Scholar
  77. 77.
    Croft P, Rigby AS, Boswell R, et al.: The prevalence of chronic widespread pain in the general population. J Rheumatol 1993, 20:710–713.PubMedGoogle Scholar
  78. 78.
    Croft P, Schollum J, Silman A: Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 1994, 309:696–699.PubMedGoogle Scholar
  79. 79.
    Yunus MB, Ahles TA, Aldag JC, Masi AT: Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum 1991, 34:15–21.PubMedGoogle Scholar
  80. 80.
    Aaron LA, Bradley LA, Alarcon GS, et al.: Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 1996, 39:436–445.Google Scholar
  81. 81.
    Yunus MB: Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Baillieres Clin Rheumatol 1994, 8:811–837.PubMedGoogle Scholar
  82. 82.
    Hawley DJ, Wolfe F: Depression is not more common in rheumatoid arthritis: a 10-year longitudinal study of 6153 patients with rheumatic disease. J Rheumatol 1993, 20:2025–2031.PubMedGoogle Scholar
  83. 83.
    Arnold LM, Iyengar SK, Khan MA, et al.: Genetic linkage of fibromyalgia to the serotonin receptor 2A region on chromosome 13 and the HLA region on chromosome 6 [Abstract]. Arthritis Rheum 2003, 48(suppl 9):S228-S229.Google Scholar
  84. 84.
    Turk DC, Okifuji A, Sinclair JD, Starz TW: Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care Res 1998, 11:397–404.PubMedGoogle Scholar
  85. 85.
    Giesecke T, Williams DA, Harris RE, et al.: Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 2003, 48:2916–2922.PubMedGoogle Scholar
  86. 86.
    Burckhardt CS, Clark SR, Bennett RM: The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991, 18:728–733. An instrument for assessing physical and psychologic functions in FMS that has been widely accepted and used.PubMedGoogle Scholar
  87. 87.
    Granges G, Littlejohn G: Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 1993, 36:642–646.PubMedGoogle Scholar
  88. 88.
    Arroyo JF, Cohen ML: Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol 1993, 20:1925–1931.PubMedGoogle Scholar
  89. 89.
    Staud R, Vierck CJ, Cannon RL, et al.: Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001, 91:165–175. This well-designed study demonstrates temporal summation, an important evidence of central sensitization in FMS.PubMedGoogle Scholar
  90. 90.
    Desmeules JA, Cedraschi C, Rapiti E, et al.: Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 2003, 48:1420–1429. This article demonstrates central sensitization in FMS regardless of patient-reported pain.PubMedGoogle Scholar
  91. 91.
    Mountz JM, Bradley LA, Modell JG, et al.: Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995, 38:926–938.PubMedGoogle Scholar
  92. 92.
    Gracely RH, Petzke F, Wolf JM, Clauw DJ: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002, 46:1333–1343.PubMedGoogle Scholar
  93. 93.
    Griep EN, Boersma JW, de Kloet ER: Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993, 20:469–474.PubMedGoogle Scholar
  94. 94.
    Crofford LJ, Pillemer SR, Kalogeras KT, et al.: Hypothalamicpituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994, 37:1583–1592.PubMedGoogle Scholar
  95. 95.
    Bennett RM, Clark SR, Campbell SM, Burckhardt CS: Low levels of somatomedin C in patients with the fibromyalgia syndrome: a possible link between sleep and muscle pain. Arthritis Rheum 1992, 35:1113–1116.PubMedGoogle Scholar
  96. 96.
    Martinez-Lavin M, Hermosillo AG: Autonomic nervous system dysfunction may explain the multi-system features of fibromyalgia. Semin Arthritis Rheum 2000, 29:197–199.PubMedGoogle Scholar
  97. 97.
    Yunus MB, Khan MA, Rawlings KK, et al.: Genetic linkage analysis of multicase families with fibromyalgia syndrome. J Rheumatol 1999, 26:408–412.PubMedGoogle Scholar
  98. 98.
    Arnold LM, Hudson JI, Hess EV, et al.: Family study of fibromyalgia. Arthritis Rheum 2004, 50:944–952.PubMedGoogle Scholar
  99. 99.
    Vaeroy H, Helle R, Forre O, et al.: Elevated CSF levels of substance P and high incidence of Raynaud’s phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988, 32:21–26. The first report of elevated substance P in the cerebrospinal fluid of patients with fibromyalgia.PubMedGoogle Scholar
  100. 100.
    Russell IJ, Orr MD, Littman B, et al.: Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994, 37:1593–1601. An important confirmation of elevated substance P in cerebrospinal fluid in patients with FMS.PubMedGoogle Scholar
  101. 101.
    Russell IJ, Michalek JE, Vipraio GA, et al.: Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992, 19:104–109.PubMedGoogle Scholar
  102. 102.
    Bennett RM, Clark SR, Goldberg L, et al.: Aerobic fitness in patients with fibrositis: a controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arthritis Rheum 1989, 32:454–460.PubMedGoogle Scholar
  103. 103.
    Buskila D, Neuman L, Vaisberg G, et al.: Increased rates of fibromyalgia following cervical spine injury: a controlled study of 161 cases of traumatic injury. Arthritis Rheum 1997, 40:446–452.PubMedGoogle Scholar
  104. 104.
    Carette S, McCain GA, Bell DA, Fam AG: Evaluation of amitriptyline in primary fibrositis: a double-blind, placebo-controlled study. Arthritis Rheum 1986, 29:655–659.PubMedGoogle Scholar
  105. 105.
    Goldenberg DL, Felson DT, Dinerman H: A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986, 29:1371–1377.PubMedGoogle Scholar
  106. 106.
    Bennett RM, Gatter RA, Campbell SM, et al.: A comparison of cyclobenzaprine and placebo in the management of fibrositis: a double-blind, controlled study. Arthritis Rheum 1988, 31:1535–1542.PubMedGoogle Scholar
  107. 107.
    Bennett RM, Kamin M, Karim R, Rosenthal N: Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebocontrolled study. Am J Med 2003, 114:537–545.PubMedGoogle Scholar

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • F. Fatma Inanici
    • 1
  • Muhammad B. Yunus
    • 1
  1. 1.Department of MedicineUniversity of Illinois College of Medicine at PeoriaPeoriaUSA

Personalised recommendations